Articles liés à Tumor Board Review: Evidence-Based Case Reviews and...

Tumor Board Review: Evidence-Based Case Reviews and Questions - Couverture souple

 
9780826145970: Tumor Board Review: Evidence-Based Case Reviews and Questions
Couverture souple
ISBN 10 : 0826145973 ISBN 13 : 9780826145970
Editeur : Springer Publishing Co Inc, 2022

Synopsis

Now in its 3rd edition, Tumor Board Review: Evidence-Based Case Reviews and Questions is the most comprehensive clinical case review book in the field. With hands-on input from current fellows and oncologists, this new edition has been enhanced and reformatted for greater efficiency and practicality.

The review covers all disease-site areas in oncology and features a wide variety of board-style questions pivotal in helping fellows and oncologists prepare for both the ABIM medical oncology board exam and maintenance of certification (MOC) assessments. Evidence-based discussions of difficult patient cases offer an in-depth and accurate depiction of what is discussed at tumor boards and foster critical thinking essential for clinical practice. Patient cases also highlight impactful treatment decisions that include newly approved immunotherapies and targeted therapies. Each chapter contains digestible essentials for each case, including a summary of diagnosis, molecular and genomic testing, treatment options, toxicity considerations, follow-up, and survivorship. Each chapter ends with high-yield multiple-choice questions including answers and detailed rationales ensuring readers are well-equipped with the knowledge they need to make well-informed, individualized treatment decisions. Tumor Board Review: Evidence-Based Case Review and Questions is an essential case-based reference for anyone working in oncology.

Key Features:

  • Describes more than 120 patient cases, including locally advanced and metastatic cases for each major disease site
  • Contains 300 board-style questions and answers related to case reviews
  • Includes new advances in diagnosis and therapy, with a greater emphasis on immunotherapies, cancer genomics, and precision-based targeted therapies
  • Provides essentials for toxicity considerations, follow-up, and survivorship considerations

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos des auteurs

Francis P. Worden, MD is a Professor of Medicine and Director of the Hematology/Oncology Fellowship Program at the University of Michigan Medical School in Ann Arbor, Michigan.



Martha Pritchett Mims, MD PhD is Professor and Chief of Hematology-Oncology at Baylor College of Medicine in Houston, Texas.



Helen K. Chew, MD is Professor of Medicine, Director of the Clinical Breast Cancer Program, and Director of the Hematology Oncology Fellowship Program at University of California Davis in Davis, California.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
Springer Publishing Co Inc
Date d'édition
2022
Langue
anglais
ISBN 10 
0826145973
ISBN 13 
9780826145970
Reliure
Broché
Numéro d'édition
3
Nombre de pages
582
Éditeur
Worden MD Francis P., Mims MD PhD Martha Pritchett, Chew MD Helen K.
Coordonnées du fabricant
non disponible
Personne responsable
GPSR Kontakt
gpsr@libri.de

Europaallee 1
Bad Hersfeld
36244
Allemagne